U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2007
205
Name Type Language
VIRGINIAMYCIN
GREEN BOOK   HSDB   INN   MART.   MI   USAN   WHO-DD  
INN   USAN  
Official Name English
VIRGINIAMYCIN [HSDB]
Common Name English
STREPTOGRAMIN
Common Name English
SK&F 7988
Code English
STAPHYLOMYCINE
Brand Name English
ESKALIN V
Brand Name English
VIRGINIAMYCIN [USAN]
Common Name English
VIRGIMYCIN
Common Name English
ESKALIN
Brand Name English
SKF-7988
Code English
VIRGINIAMYCIN [MART.]
Common Name English
LACTROL
Brand Name English
ESKALIN 500
Brand Name English
STAPHYLOMYCIN
Common Name English
virginiamycin [INN]
Common Name English
VIRGINIAMYCIN [MI]
Common Name English
STAPYOCINE
Brand Name English
ANTIBIOTIC PRODUCED BY STREPTOMYCES VIRGINIAE; A MIXTURE OF TWO PRINCIPAL ANTIBIOTIC COMPONENTS, VIRGINIAMYCIN M1 (FACTOR M1) AND VIRGINIAMYCIN S1 (FACTOR S)
Common Name English
VIRGINIAMYCIN [GREEN BOOK]
Common Name English
Virginiamycin [WHO-DD]
Common Name English
RP-7293
Code English
SK&F-7988
Code English
LIVELONG
Brand Name English
V-MAX
Brand Name English
Classification Tree Code System Code
WHO-ATC D06AX10
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
CFR 21 CFR 556.750
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
WHO-VATC QD06AX10
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
CFR 21 CFR 558.635
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
WHO-VATC QJ01FG90
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
Code System Code Type Description
EVMPD
SUB05111MIG
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
PRIMARY
CAS
11006-76-1
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
PRIMARY
MERCK INDEX
m11470
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
PRIMARY Merck Index
RXCUI
11232
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
PRIMARY RxNorm
FDA UNII
C49WS9N75L
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
PRIMARY
NCI_THESAURUS
C937
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
PRIMARY
MESH
D014769
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
PRIMARY
INN
1269
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
PRIMARY
ChEMBL
CHEMBL2146161
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
PRIMARY
DAILYMED
C49WS9N75L
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
PRIMARY
HSDB
7033
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
PRIMARY
CHEBI
87209
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
PRIMARY
EPA CompTox
DTXSID40880080
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
PRIMARY
DRUG CENTRAL
4028
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
PRIMARY
ECHA (EC/EINECS)
234-244-6
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
PRIMARY
WIKIPEDIA
Virginiamycin
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
PRIMARY
DRUG BANK
DB11476
Created by admin on Sat Dec 16 16:31:31 GMT 2023 , Edited by admin on Sat Dec 16 16:31:31 GMT 2023
PRIMARY
All of the following components must be present:
Structure of QUINUPRISTIN
Structure of DALFOPRISTIN
ACTIVE MOIETY
VIRGINIAMYCIN
Definition References
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966